Prevalence of <scp>HIV</scp> , <scp>HBV</scp> , and <scp>HCV</scp> in United States blood donations, 2015–2023: The transfusion‐transmissible infections monitoring system ( <scp>TTIMS</scp> )

Despite reducing donor deferral periods for many infectious risk behaviors, HIV and HBV prevalence were stable, while HCV prevalence declined over 8 years. Either slight or significant declines occurred from the pre-3M to 3M period for all agents. Thus, changes in policy did not adversely impact the current safety of the blood supply with respect to the major infectious disease agents.